Buy 3 and get 1 for FREE
Dragon Pharma, Europe
Oral Tren
Oral · 250 mcg · 100 tabs
$39.00
Buy 3 and get 1 for FREE
Buy 5+ for $36.27 and save $13.65
Compound ID
Methyltrienolone
Dosage
25 mcg/day
Concentration
250 mcg/tablet
Form
100 Tablets × 250 mcg
Half-life
4–6 hours
Properties
Shipping
Not available in this combination
Product overview
Dragon Pharma Methyltrienolone 250mcg — Ultra-Potent Oral Hardening Agent for Competition-Grade Density & Vascularity
Dragon Pharma Methyltrienolone 250mcg, recognized throughout elite physique circles as Oral Tren, represents the absolute apex of oral anabolic potency—a compound so formidable that its dosage is measured in micrograms rather than milligrams. This 17-alpha-alkylated derivative of Trenbolone delivers a level of androgen receptor affinity and anabolic intensity unmatched by virtually any other tablet in the performance enhancement landscape. Engineered specifically for advanced bodybuilders seeking extreme muscular hardness, grainy detail, and pronounced venous mapping during cutting or pre-contest phases, each precisely dosed 250mcg tablet produces visually striking recomposition effects within days.
Dragon Pharma's pharmaceutical-grade manufacturing ensures exact potency and batch consistency, providing experienced athletes with a verified tool for achieving the most aggressive conditioning possible—provided its severe hepatotoxic and suppressive profile is managed with meticulous precision.
What is Dragon Pharma Methyltrienolone?
Methyltrienolone is a synthetic oral anabolic-androgenic steroid derived from Trenbolone through the addition of a 17-alpha-methyl group, enabling oral bioavailability by resisting first-pass hepatic degradation. This structural modification creates a compound with extraordinary binding affinity for the androgen receptor—among the highest of any anabolic agent ever synthesized—while simultaneously introducing profound hepatotoxic liability. Unlike its injectable parent hormone, Methyltrienolone does not aromatize to estrogen, eliminating water retention and gynecomastia risk. However, it retains progestogenic activity, which can stimulate progesterone receptors in sensitive tissues.
Originally developed for veterinary and research applications, this agent has found its niche among advanced physique competitors who require extreme dryness, density, and strength enhancement in abbreviated timeframes. Dragon Pharma's 250mcg tablets provide the precise micro-dosing control essential for safe administration of this extraordinarily potent compound.
Key Benefits / Effects
- Extreme Muscular Hardening: Users experience a rapid shift toward dry, grainy, and striated tissue quality as subcutaneous fluid evacuates and intramuscular density increases, producing a carved-stone aesthetic ideal for stage presentation.
- Exceptional Venous Prominence: Reduced water retention combined with increased hematocrit and vascular tone creates dramatic vein visibility even in rested states, with vascular patterns appearing in previously unseen anatomical locations.
- Explosive Neuromuscular Strength: The compound's potent androgen receptor activation enhances neuromuscular transmission efficiency, frequently producing personal record lifts within the first 10–14 days of administration.
- Accelerated Lipolytic Recomposition: Strong androgenic signaling upregulates metabolic rate and encourages adipose tissue mobilization, supporting simultaneous fat reduction and lean tissue preservation during hypocaloric phases.
- Absence of Estrogenic Complications: Non-aromatizing structure eliminates gynecomastia risk, subcutaneous edema, and estrogen-mediated blood pressure elevation, streamlining side-effect management.
- Rapid Onset of Visual Changes: Unlike slower-acting injectables, Oral Tren produces noticeable physique alterations in hardness, vascularity, and muscle separation within the first week of use.
How Dragon Pharma Methyltrienolone Works
Methyltrienolone operates through ultra-high-affinity binding to androgen receptors within skeletal muscle, adipose tissue, and the central nervous system, initiating a conformational cascade that upregulates anabolic gene transcription while downregulating lipogenic enzyme expression. In myocytes, this activation dramatically increases muscle protein synthesis, enhances myofibrillar contractile density, and promotes nitrogen retention without the fluid accumulation associated with estrogenic compounds.
Simultaneously, the compound elevates red blood cell production through erythropoietic stimulation, improving oxygen delivery and muscular endurance despite its non-aromatizing nature. The 17-alpha-alkylation, while essential for oral survival, subjects the compound to hepatic metabolism via cytochrome P450 enzymes, generating substantial oxidative stress within hepatocytes. Additionally, Methyltrienolone exhibits affinity for progesterone receptors, which in rare cases can contribute to progestogenic gynecomastia in hypersensitive individuals. The net physiological result is a rapid, dramatic shift toward extreme leanness, hardness, and strength that must be balanced against equally significant physiological cost.
Usage Information
Dragon Pharma Methyltrienolone is supplied as 250mcg oral tablets and is reserved exclusively for advanced male athletes with extensive prior anabolic experience. Due to its extraordinary potency and severe hepatotoxicity, cycle duration must be strictly limited to 4–6 weeks maximum. Experienced users typically initiate at 250–500mcg daily, often split into two administrations to maintain stable plasma concentrations. A minority of advanced bodybuilders may briefly explore 750mcg to 1mg daily, though doses approaching 1mg exponentially increase hepatic and cardiovascular risk with diminishing aesthetic returns. Beginners should avoid this compound entirely.
Oral Tren is almost exclusively deployed during cutting or pre-contest phases and is frequently paired with non-aromatizing injectable bases such as Testosterone Propionate or Drostanolone to enhance hardness without introducing estrogenic variables. Liver support supplementation is absolutely mandatory throughout use, and comprehensive blood work must precede, accompany, and follow any cycle. Post-Cycle Therapy must begin shortly after the final dose to restore endogenous testosterone production.
Quality & Manufacturing
Dragon Pharma maintains exacting pharmaceutical manufacturing standards, with each Methyltrienolone batch subjected to independent third-party laboratory analysis to verify identity, purity, and micro-dosing accuracy. Given that this compound is active at microgram rather than milligram quantities, manufacturing precision is paramount—minor deviations in tablet homogeneity could produce dangerously unpredictable effects. Dragon Pharma's quality-control protocols ensure uniform distribution of the active agent within each 250mcg dose unit, eliminating the hot spots or underdosed regions that could compromise safety or efficacy. In the advanced oral steroid marketplace, where micro-dosed compounds are frequently mislabeled or contaminated, this level of analytical rigor provides experienced users with the confidence to administer this formidable agent with the precision required for both maximum results and harm reduction.
Possible Side Effects / Safety Information
- Severe Hepatotoxicity: Methyltrienolone ranks among the most liver-toxic oral steroids available. Even brief cycles at moderate doses can produce dramatic elevations in hepatic transaminases. Cycle length must not exceed 6 weeks, and aggressive liver support is mandatory.
- Profound HPTA Suppression: The compound rapidly and completely shuts down endogenous testosterone production, necessitating a testosterone base during cycles and comprehensive Post-Cycle Therapy afterward.
- Intense Androgenic Manifestations: Users frequently experience severe acne, accelerated male pattern baldness in genetically predisposed individuals, increased terminal hair growth, and heightened aggression or irritability.
- Progestogenic Gynecomastia Risk: Although non-aromatizing, the compound's progestogenic activity can stimulate mammary tissue proliferation in sensitive individuals, particularly when combined with other progestogenic agents.
- Cardiovascular Strain: Significant blood pressure elevation, adverse lipid profile shifts including HDL depression and LDL elevation, and increased hematocrit contribute to substantial cardiometabolic stress.
- Neuropsychological Disturbances: Insomnia, night sweats, anxiety, and "Tren rage"—marked irritability and aggression—are commonly reported and can impair daily functioning and interpersonal relationships.
- Gastrointestinal Intolerance: Nausea, appetite suppression, and general digestive discomfort may occur, complicating nutritional adherence during critical pre-contest phases.
- Absolute Beginner Contraindication: This compound is inappropriate for novice users under all circumstances due to its extreme potency and narrow therapeutic window.
Why Choose Dragon Pharma Methyltrienolone?
When manipulating a compound active at microgram concentrations, manufacturing precision and dosing consistency become matters of critical safety rather than mere convenience. Dragon Pharma's rigorous batch testing and quality-assurance protocols ensure that each 250mcg tablet delivers exactly the stated pharmacological payload, eliminating the dangerous variability that plagues unverified or underground micro-dosed products. For advanced bodybuilders who have exhausted milder cutting agents and demand the most extreme level of muscular hardness, vascularity, and density achievable in oral form, this verified formulation provides a precisely quantified tool. The brand's commitment to analytical transparency transforms what could be a hazardous guess into a calculated, informed protocol for competition-level conditioning.
Have used this source for a couple years now and never anything bad. The tren orals has me sweating extra in the gym.
I’ve been getting my gear from here for a couple years now and I’m extremely happy!! Orders come in relatively quickly !! I’ve had great results with everything I’ve tried. Test cyp test e and oral tren. Plus they surprised me with a little extra samples of stuff. Highly recommend this site!!!
As a Dialysis patient things haven't been easy. But after coming across this company I'm back in the gym and at 47 I'm benching 325 again. Tren is the truth. Will be ordering other products.
Definitely is a good product to add on to a cycle. Can be administered fast, that makes it effective for timing.
this tren is very powerful I know from my own experience, but it also gives you very good results, package was discrete, and all tabs were intact. Never getting issues from this source. Excellent customer service
Product FAQ
Questions, answered
Methyltrienolone possesses an androgen receptor binding affinity and anabolic potency so extreme that effective doses are measured in micrograms—roughly 1/1000th of a gram. A 250–500mcg dose produces effects comparable to several milligrams of less potent oral steroids. This micro-dosing requirement reflects the compound's extraordinary pharmacological efficiency and underscores why even minor dosing errors or tablet inconsistencies could produce dangerous outcomes.
Oral Tren is among the fastest-acting anabolic agents available. Most advanced users report noticeable increases in muscle hardness, vascularity, and training aggression within the first 5–7 days. Visible physique changes including enhanced separation, striations, and vein prominence typically consolidate by week 2, with maximal conditioning effects appearing during weeks 3–5. The rapid onset makes it ideal for brief, intense pre-contest or peaking protocols.
Stacking Methyltrienolone with other C17-alpha alkylated compounds is strongly discouraged and considered dangerous by virtually all experienced practitioners. The combined hepatotoxic burden from multiple liver-stressing orals can produce severe, potentially irreversible hepatic damage. If combination therapy is desired, it should be limited to non-alkylated injectable agents such as Testosterone Propionate, Drostanolone, or Methenolone. Oral Tren should be the sole oral compound in any protocol.
While Methyltrienolone does not convert to estrogen via aromatase, it retains affinity for progesterone receptors. In sensitive individuals, this progestogenic activity can stimulate mammary tissue growth independently of estrogen—a phenomenon known as progestogenic gynecomastia. Users employing a testosterone base must manage estrogen from the exogenous testosterone, and those particularly sensitive to progestogenic effects may benefit from prolactin-modulating agents like Cabergoline or from avoiding other progestogenic compounds in the same stack.
Yes. Methyltrienolone rapidly and completely suppresses endogenous testosterone production, producing severe low-androgen symptoms including lethargy, libido collapse, erectile dysfunction, and depression. A testosterone base—typically 200–400mg weekly of Testosterone Propionate or Enanthate—maintains physiological androgen levels, preserving mental clarity, sexual function, and training intensity while Oral Tren drives extreme conditioning. Because testosterone aromatizes, an aromatase inhibitor may be needed to manage estrogen.
Given its ranking as one of the most hepatotoxic oral steroids, Methyltrienolone requires the most aggressive liver protection available. Standard protocols include TUDCA at 750–1000mg daily and N-acetylcysteine (NAC) at 1200–2400mg daily. Additional support may include milk thistle, Liv-52, or glutathione precursors. Complete alcohol abstinence is mandatory, as is avoidance of acetaminophen, NSAIDs, and all other hepatotoxic substances. Pre-cycle liver enzyme baselines must be established, with mid-cycle monitoring at week 3 to assess hepatic status.
Injectable Trenbolone (typically Acetate or Enanthate) offers comparable androgenic potency with significantly reduced hepatotoxicity due to absence of C17-alpha alkylation. Oral Tren provides more rapid onset and convenience but imposes far greater liver stress, requires shorter cycles, and carries a higher overall risk profile. Injectable Trenbolone is generally preferred for longer, sustained cutting or recomposition phases, while Oral Tren is reserved for brief, aggressive peaking protocols where rapid visual changes are paramount.
PCT must begin within 24–48 hours of the final dose due to profound suppression. A comprehensive protocol includes Clomiphene Citrate at 50/50/25/25mg and Tamoxifen Citrate at 40/20/20/20mg over four weeks. For users who employed a testosterone base, PCT timing should account for ester clearance—Propionate bases allow earlier PCT initiation than Enanthate or Cypionate. HCG at 500–1000IU every other day for the two weeks preceding SERM administration can prime testicular responsiveness. Blood work confirming recovered LH, FSH, and total testosterone must precede any subsequent cycle.
Absolutely not. Methyltrienolone's extreme androgenic potency produces rapid, irreversible virilization even at micro-doses that would be imperceptible for male users. Female exposure would result in near-certain voice deepening, clitoral enlargement, facial and body hair growth, and menstrual cessation within days. Unlike milder compounds where conservative female protocols exist, Oral Tren carries no safe therapeutic window for women and is categorically contraindicated under all circumstances.
Baseline panels must include total and free testosterone, estradiol, prolactin, complete blood count, comprehensive metabolic panel with liver enzymes (ALT, AST, ALP, GGT, bilirubin), and a full lipid profile. Blood pressure should be monitored every 48–72 hours due to the compound's hypertensive potential. Mid-cycle testing at week 3 identifies emerging hepatic stress, hematocrit elevation, or dyslipidemia. Post-cycle panels at weeks 2 and 4 after cessation confirm hormonal recovery and metabolic normalization. Given the extreme risk profile, these safeguards are absolutely non-negotiable.
